Una aproximación a la medicina complementaria y alternativa en el contexto de su desarrollo como industria en el Perú

Una aproximación a la medicina complementaria y alternativa en el contexto de su desarrollo como industria en el Perú

Javier Alberto González Chang

Seguro Social de Salud (EsSalud).


Resumen

La presente revisión busca enfatizar y poner en foco la importancia de un esfuerzo coordinado para desarrollar la medicina complementaria y alternativa (CAM en inglés) en el Perú, en la próxima década, señalando que se requiere analizar, también, el entorno económico en función a la demanda real y las ventajas diferenciales que lo integran en la matriz de la industria de la salud, a fin de reafirmar las variables críticas para su desarrollo y sostenibilidad futura. También, se advierte la importancia de una sólida ejecución de investigación clínica en medicina complementaria y alternativa, por ser transversal entre los varios objetivos de consolidación, así como el compromiso de la academia, la industria y los órganos de decisión en relación a un adecuado marco normativo, para facilitar la materialización de una visión compatible al liderazgo sustantivo del Perú en la región.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Javier Alberto González Chang, Seguro Social de Salud (EsSalud).

Jefatura de Investigación e Innovación de la Red Desconcentrada Rebagliati - EsSalud. Lima, Perú

Economista, MBA.


Referencias

Ng JY, Boon HS, Thompson AK, Whitehead CR. Making sense of “alternative”, “complementary”, “unconventional” and “integrative” medicine: exploring the terms and meanings through a textual analysis. BMC Complement Altern Med [Internet]. 2016 May 20 [cited 2017 Jan 12];16. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875612/

NCCAM Third Strategic Plan: 2011–2015 [Internet]. NCCIH. 2011 [cited 2017 Jan 13]. Available from: https://nccih.nih.gov/about/plans/2011

Castañeda BC, Llica ER, Vásquez LI. Evaluación de la capacidad antioxidante de siete plantas medicinales peruanas. Horizonte Médico [Internet]. 2008 Dec 30 [cited 2017 Jan 13];8(1). Available from: http://www.horizontemedicina.usmp.edu.pe/index.php/horizontemed/article/view/196

Skalli S, Jordan SA. Herbal and Traditional Medicines, Now and Future. In: Edwards IR, Lindquist M, editors. Pharmacovigilance [Internet]. Springer International Publishing; 2017 [cited 2017 Jan 12]. p. 145–59. Available from: http://link.springer.com/chapter/10.1007/978-3-319-40400-4_14

Wang J, Xiong X. Current Situation and Perspectives of Clinical Study in Integrative Medicine in China. Evidence-Based Complementary and Alternative Medicine. 2012 Apr 10;2012:e268542.

Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complementary Therapies in Medicine. 2002 Jun 1;10(2):84–93.

Frawley J. Complementary and alternative medicine in Australia: An overview of contemporary workforce features. Australian Journal of Herbal Medicine. 2016;28(4):103.

Susanne Schunder. Complementary and Alternative Medicine in Europe [Internet]. IHP. 2016 [cited 2017 Jan 12]. Available from: http://ihpmagazine.com/complementary-and-alternative-medicine-in-europe/

Institute of Medicine (US) Committee on the Use of Complementary and Alternative Medicine by the American Public. Complementary and Alternative Medicine in the United States [Internet]. Washington (DC): National Academies Press (US); 2005 [cited 2017 Jan 12]. (The National Academies Collection: Reports funded by National Institutes of Health). Available from: http://www.ncbi.nlm.nih.gov/books/NBK83799/

Walach H. CAMbrella – Complementary Medicine Research in Europe. Complement Med Res. 2012 Nov 1;19(Suppl. 2):1–2.

De Herdt N, Schunder-Tatzber S. Before and after CAMbrella. Complement Med Res. 2014 Mar 24;21(2):82–3.

Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, et al. A Systematic Literature Review of Complementary and Alternative Medicine Prevalence in EU. Complement Med Res. 2012 Nov 1;19(Suppl. 2):18–28.

Vincent C, Furnham A. Why do patients turn to complementary medicine? An empirical study. British Journal of Clinical Psychology. 1996 Feb 1;35(1):37–48.

Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA Journal. 2016;7:23.

Cáncer: en detalles [Internet]. NCCIH. 2012 [cited 2017 Jan 11]. Available from: https://nccih.nih.gov/node/3868

Sagar SM. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals (2009). J Soc Integr Oncol. 2009;7(3):83–4.

Spence DS, Thompson EA, Barron S j. Homeopathic Treatment for Chronic Disease: A 6-Year, University-Hospital Outpatient Observational Study. The Journal of Alternative and Complementary Medicine. 2005 Oct 1;11(5):793–8.

Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ. 2004 Mar 25;328(7442):747.

Kraft K. Complementary/Alternative Medicine in the context of prevention of disease and maintenance of health. Preventive Medicine. 2009 Aug;49(2–3):88–92.

Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ. 2012 Dec 1;13(6):769–76.

Johnson PJ, Ward A, Knutson L, Sendelbach S. Personal Use of Complementary and Alternative Medicine (CAM) by U.S. Health Care Workers. Health Serv Res. 2012 Feb 1;47(1pt1):211–27.

Peña A, Paco O. Medicina alternativa: intento de análisis. Anales de la Facultad de Medicina. 2007 Mar;68(1):87–96.

Rastegar DA. Health Care Becomes an Industry. Ann Fam Med. 2004 Jan 1;2(1):79–83.

Godoy MA. ¿Porqué la Medicina Complementaria? Revista Chilena de Pediatría. 2003 Jan;74(1):114–6.

Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing Epidemics: The Role of Global Producers in Increased Consumption of Unhealthy Commodities Including Processed Foods, Alcohol, and Tobacco. PLOS Medicine. 2012 Jun 26;9(6):e1001235.

Stuckler, D., Reeves, A., Loopstra, R., & McKee, M. (2016). Textual analysis of sugar industry influence on the World Health Organization’s 2015 sugars intake guideline. Bulletin of the World Health Organization, 94(8), 566-73.

Hritcu L, Cioanca O. Prevalence of Use of Herbal Medicines and Complementary and Alternative Medicine in Europe. In: Grosso C, editor. Herbal Medicine in Depression [Internet]. Springer International Publishing; 2016 [cited 2016 Dec 28]. p. 135–81. Available from: http://link.springer.com/chapter/10.1007/978-3-319-14021-6_5

Porter ME. Competitive Advantage: Creating and Sustaining Superior Performance. Simon and Schuster; 2008. 602 p.

Rivers PA, Glover SH. Health care competition, strategic mission, and patient satisfaction: research model and propositions. J of Health Org and Mgt. 2008 Oct 31;22(6):627–41.

Ajazuddin, Saraf S. Legal regulations of complementary and alternative medicines in different countries. Pharmacogn Rev. 2012;6(12):154–60.

footer_infoedutec